Dimethyl fumarate Mylan Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Vocabria 30 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 30 mg compresse rivestite con film

viiv healthcare gmbh - cabotegravirum - compresse rivestite con film - cabotegravirum 30 mg ut cabotegravirum natricum, lactosum monohydricum 163.59 mg, cellulosum microcristallinum, hypromellosum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum e 171, macrogolum 400, pro compresso obducto corresp. natrium 2.67 - 3.59 mg. - l'infezione da hiv - synthetika

DIMETILFUMARATO PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dimetilfumarato piramal

piramal critical care italia s.p.a. - dimethyl fumarate - dimethyl fumarate

Apretude Unione Europea - italiano - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - infezioni da hiv - antivirali per uso sistemico - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 e 5.

Vocabria 400 mg / 2 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 400 mg / 2 ml deposito-injektionssuspension

viiv healthcare gmbh - cabotegravirum - deposito-injektionssuspension - cabotegravirum 400 mg, mannitolum, polysorbatum 20, macrogolum 3350, aqua ad iniectabile, ad solutionem pro 2 ml. - l'infezione da hiv - synthetika

Vocabria 600 mg / 3 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 600 mg / 3 ml deposito-injektionssuspension

viiv healthcare gmbh - cabotegravirum - deposito-injektionssuspension - cabotegravirum 600 mg, mannitolum, polysorbatum 20, macrogolum 3350, aqua ad iniectabile, ad solutionem pro 3 ml. - l'infezione da hiv - synthetika